微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 37.73% | 1.89% | 6.07% | 94/139 | 51.97% | 佰仁医疗 | 88.17% | 行业排名> |
| 2025-12-31 | 35.57% | -15.82% | -7.5% | 99/139 | 51.43% | 佰仁医疗 | 89.18% | 行业排名> |
| 2025-09-30 | 38.45% | 2% | 0.98% | 93/139 | 51.66% | 佰仁医疗 | 88.17% | 行业排名> |
| 2025-06-30 | 38.08% | -16.44% | 2.85% | 94/139 | 51.8% | 佰仁医疗 | 88.54% | 行业排名> |
| 2025-03-31 | 37.03% | 2% | -12.37% | 96/139 | 51.48% | 佰仁医疗 | 85.72% | 行业排名> |
| 2024-12-31 | 42.25% | 6.72% | -7.29% | 89/139 | 52.35% | 佰仁医疗 | 88.34% | 行业排名> |
| 2024-06-30 | 45.58% | 4.3% | 15.11% | 84/139 | 53.35% | 佰仁医疗 | 88.56% | 行业排名> |
| 2023-12-31 | 39.59% | 0.8% | -9.4% | 98/139 | 53.18% | 佰仁医疗 | 89.27% | 行业排名> |
| 2023-06-30 | 43.7% | 2% | 11.25% | 89/139 | 53.47% | 佰仁医疗 | 89.28% | 行业排名> |
| 2022-12-31 | 39.28% | 2% | 2% | 98/139 | 53.71% | 正海生物 | 89.9% | 行业排名> |